Corrigendum to "Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma" [Clinical Immunology 255 (2023) 109755]
Clin Immunol. 2023 Dec:257:109841.
doi: 10.1016/j.clim.2023.109841.
Epub 2023 Nov 17.
1 Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea.
2 Department of Allergy and Clinical Immunology, Ajou University Medical School, Suwon 16499, Republic of Korea.
3 Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea; Department of Allergy and Clinical Immunology, Ajou University Medical School, Suwon 16499, Republic of Korea. Electronic address: kimys@ajou.ac.kr.